Endometrial Cycle and Histology for OB-GYN Boards | MDster You are offline Back online! [ ](/) Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Endometrial Cycle and Histology: How to Read the Monthly Biopsy [ Medical Education ](https://mdster.com/blog?category=medical-education) Endometrial Cycle and Histology: How to Read the Monthly Biopsy ================================================================= A board-focused guide to proliferative and secretory endometrium, histologic dating, and the physiology behind withdrawal bleeding [ MDster Editorial Team ](https://mdster.com/about) · Mar 16, 2026 · 6 min read · 73 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Obstetrics & Gynecology ](https://mdster.com/blog?tag=obstetrics-gynecology) [ Reproductive Endocrinology ](https://mdster.com/blog?tag=reproductive-endocrinology) [ OBGYN Boards ](https://mdster.com/blog?tag=obgyn-boards) [ Endometrial Histology ](https://mdster.com/blog?tag=endometrial-histology) [ Abnormal Uterine Bleeding ](https://mdster.com/blog?tag=abnormal-uterine-bleeding) Share this article Share this post Every gynecology trainee eventually sees a biopsy report that says **proliferative endometrium**, **secretory endometrium**, or the vague and usually unhelpful **out-of-phase**. If you do not have a clean mental model of what estrogen builds, what progesterone differentiates, and what progesterone withdrawal destroys, that report is just noise. This matters on boards, but it matters even more in clinic: a proliferative biopsy in an oligo-ovulatory patient is not trivia — it is a clue to chronic unopposed estrogen and future endometrial risk. [\[1\]](#cite-1 "Reference [1]") Think in layers, not just cycle days ------------------------------------ Start with architecture. The **stratum functionalis** is the hormonally responsive upper layer; it grows, differentiates, and is shed. The **stratum basalis** is the deeper regenerative layer that remains behind and rebuilds the surface after menses. Under rising estradiol in the follicular phase, glands, stroma, and vasculature proliferate. After ovulation, corpus luteum progesterone converts that estrogen-primed lining into a secretory, implantation-ready endometrium. If implantation does not occur, the functionalis is shed and the basalis repairs the surface without scarring. That simple layered model explains most normal and abnormal biopsy findings. [\[1\]](#cite-1 "Reference [1]") Proliferative versus secretory change ------------------------------------- On microscopy, **proliferative endometrium** is an estrogen story. Expect relatively straight to mildly tortuous tubular glands, pseudostratified columnar nuclei, mitotic activity, and a dense cellular stroma. It looks busy because it is growing. **Secretory endometrium** is a progesterone story layered onto prior estrogen exposure. Early after ovulation, the giveaway is **subnuclear vacuoles**. Then secretion moves into the gland lumen, glands become more tortuous, stromal edema appears, spiral arterioles become more conspicuous, and late in the cycle the stroma shows **predecidual change**, first around arterioles and then more diffusely. [\[2\]](#cite-2 "Reference [2]") FeatureProliferative endometriumSecretory endometriumDominant hormonal driverEstradiolProgesterone after ovulationGlandsStraight/tubular, pseudostratified, mitotically activeTortuous, vacuolated, then luminal secretions and saw-tooth contoursStroma/vesselsDense cellular stroma, less conspicuous spiral arteriolesStromal edema, prominent spiral arterioles, periarteriolar then diffuse predecidualizationClinical meaningNormal follicular phase; if persistent, think anovulation/unopposed estrogenConfirms progesterone exposure and likely ovulation *Use this table as a pattern-recognition tool, not a substitute for cycle context.* [\[2\]](#cite-2 "Reference [2]") Histologic dating: useful concept, limited clinical test -------------------------------------------------------- Classic **histologic dating** — the Noyes-style approach — works because secretory change follows a reasonably orderly sequence after ovulation. Early secretory endometrium shows subnuclear vacuoles; then vacuoles migrate, intraluminal secretion peaks, stromal edema follows, and periarteriolar predecidualization appears late. Boards love that sequence because it ties histology directly to ovulation and progesterone exposure. But do not over-romanticize it in real practice. ASRM states that histologic dating with endometrial biopsy is **not recommended** for routine infertility evaluation or for diagnosing luteal phase deficiency because accuracy and reproducibility are poor. So keep the concept for physiology and exam logic, but do not pretend a single biopsy can precisely tell you reproductive destiny. [\[3\]](#cite-3 "Reference [3]") Withdrawal bleeding physiology ------------------------------ Withdrawal bleeding is not passive tissue sloughing. It is a programmed response to **loss of progesterone support**. When pregnancy does not occur, rising hCG never rescues the corpus luteum, progesterone falls, and that withdrawal is the key trigger for menstruation. Locally, progesterone withdrawal permits inflammatory signaling, apoptosis, prostaglandin activity, matrix metalloproteinase activation, and extracellular matrix breakdown in the upper functional layer. Spiral arteriolar vasoconstriction, hemorrhage, shedding, hemostasis, and then rapid re-epithelialization from the basalis follow in sequence. If vasoconstriction or repair is inefficient, heavy menstrual bleeding follows. Clinically, this is why a **progestin challenge** only makes sense in an estrogen-exposed endometrium: bleeding after withdrawal suggests prior estrogen effect and an intact outflow tract, whereas no bleeding raises concern for hypoestrogenism, endometrial damage, or obstruction. [\[4\]](#cite-4 "Reference [4]") Clinical correlations --------------------- Now apply the physiology. A biopsy showing **proliferative endometrium** in a patient with months of oligomenorrhea usually means chronic anovulation: estrogen keeps building the lining, but there is no corpus luteum and no synchronized progesterone withdrawal. The result is irregular, incomplete shedding and, over time, risk of hyperplasia or carcinoma. Think PCOS, obesity, adolescence, perimenopause, thyroid disease, hyperprolactinemia, or hypothalamic dysfunction. By contrast, a **secretory endometrium** tells you progesterone reached the tissue, but it does **not** prove ideal luteal timing, implantation competence, or a diagnosable luteal phase defect. [\[5\]](#cite-5 "Reference [5]") > **Clinical Pearl:** On a board stem, irregular menses plus a biopsy with proliferative endometrium and no secretory change should make you think **anovulation with unopposed estrogen**. If the slide shows **subnuclear vacuoles**, think **early post-ovulatory progesterone effect**. [\[5\]](#cite-5 "Reference [5]") Key Takeaways ------------- - **Estrogen builds; progesterone differentiates; progesterone withdrawal bleeds.** That is the core endometrial cycle in one line. [\[1\]](#cite-1 "Reference [1]") - **Proliferative endometrium** shows tubular glands, pseudostratification, mitoses, and dense cellular stroma. [\[2\]](#cite-2 "Reference [2]") - **Secretory endometrium** progresses from subnuclear vacuoles to luminal secretion, stromal edema, prominent spiral arterioles, and predecidualization. [\[6\]](#cite-6 "Reference [6]") - **Histologic dating is a good teaching model but a poor routine infertility test.** ASRM does not recommend biopsy dating to diagnose luteal phase deficiency. [\[7\]](#cite-7 "Reference [7]") - **Withdrawal bleeding requires a sufficiently estrogenized endometrium and intact outflow.** Chronic anovulation causes unsynchronized bleeding and increases hyperplasia risk. [\[8\]](#cite-8 "Reference [8]") Conclusion ---------- If you remember nothing else, remember this: the endometrium is a live readout of the HPO axis. Read the biopsy by asking which hormone has been acting, whether ovulation happened, and whether progesterone was ever present — then the histology stops being decorative and starts becoming clinically useful. [\[9\]](#cite-9 "Reference [9]") References (14) ------------------- 1. 1. [ pmc.ncbi.nlm.nih.gov/articles/PMC9098793 ](https://pmc.ncbi.nlm.nih.gov/articles/PMC9098793/) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ webpath.med.utah.edu/HISTHTML/NORMAL/NORM048.html ](https://webpath.med.utah.edu/HISTHTML/NORMAL/NORM048.html) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ pmc.ncbi.nlm.nih.gov/articles/PMC7439867 ](https://pmc.ncbi.nlm.nih.gov/articles/PMC7439867/) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ pubmed.ncbi.nlm.nih.gov/32031903 ](https://pubmed.ncbi.nlm.nih.gov/32031903/) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ www.msdmanuals.com/en-jp/professional/gynecology-and-obstetrics/menstrual-abnormalities/abnormal-uterine-bleeding-due-to-ovulatory-dysfunction-aub-o ](https://www.msdmanuals.com/en-jp/professional/gynecology-and-obstetrics/menstrual-abnormalities/abnormal-uterine-bleeding-due-to-ovulatory-dysfunction-aub-o) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ webpath.med.utah.edu/FEMHTML/FEM067.html ](https://webpath.med.utah.edu/FEMHTML/FEM067.html) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ integration.asrm.org/globalassets/\_asrm/practice-guidance/practice-guidelines/pdf/clinical-relevance-of-luteal-phase-deficiency.pdf ](https://integration.asrm.org/globalassets/_asrm/practice-guidance/practice-guidelines/pdf/clinical-relevance-of-luteal-phase-deficiency.pdf) [↩](#cite-ref-7-1 "Back to text") 8. 8. [ www.ncbi.nlm.nih.gov/books/NBK279144 ](https://www.ncbi.nlm.nih.gov/books/NBK279144/) [↩](#cite-ref-8-1 "Back to text") 9. 9. [ webpath.med.utah.edu/HISTHTML/NORMAL/NORMAL13.html ](https://webpath.med.utah.edu/HISTHTML/NORMAL/NORMAL13.html) [↩](#cite-ref-9-1 "Back to text") 10. 10. Practice Committees of the American Society for Reproductive Medicine and the Society for Reproductive Endocrinology and Infertility. Diagnosis and treatment of luteal phase deficiency: a committee opinion. Fertility and Sterility. 2021;115(6):1416-1423. 11. 11. Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertility and Sterility. 2021;116(5):1255-1265. 12. 12. Jain V, Chodankar RR, Maybin JA, Critchley HOD. Uterine bleeding: how understanding endometrial physiology underpins menstrual health. Nature Reviews Endocrinology. 2022;18(5):290-308. 13. 13. Critchley HOD, Maybin JA, Armstrong GM, Williams ARW. Physiology of the Endometrium and Regulation of Menstruation. Physiological Reviews. 2020;100(3):1149-1179. 14. 14. WebPath teaching pages, University of Utah/Mercer University School of Medicine. Female genital tract and normal endometrial histology resources, accessed March 2026. Next Build confidence in OB/GYN with focused practice -------------------------------------------------- - Labor & delivery + postpartum essentials - Gynecology, screening, and common procedures - Review weak topics and improve faster [ Start practicing ](https://mdster.com/user/dashboard) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() Related Posts ------------- [ ![Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap](https://mdster.com/storage/blog/images/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap.jpg) Medical Education ### Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap A focused Family Medicine review of anxiety, depression, and dyspnea in severe COPD/asthma overlap, with safer prescribing, breathing retraining, and board-style pitfalls. 6 min read 0 comments ](https://mdster.com/blog/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap) [ ![IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy](https://mdster.com/storage/blog/images/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy.jpg) Medical Education ### IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy A focused Internal Medicine review of IBS diagnosis: how to use Rome IV concepts, separate IBS-C from IBS-D and mixed IBS, and decide when colonoscopy is truly indicated. 7 min read 0 comments ](https://mdster.com/blog/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy) [ ![Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes](https://mdster.com/storage/blog/images/congenital-hypothyroidism-screening-levothyroxine-outcomes.jpg) Medical Education ### Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes High-yield review of congenital hypothyroidism for Pediatrics trainees, covering newborn screening pitfalls, urgent levothyroxine treatment, and developmental follow-up. 6 min read 0 comments ](https://mdster.com/blog/congenital-hypothyroidism-screening-levothyroxine-outcomes) [ ](/) Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) ### Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) ### Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) ### Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept